Even though most data come from studies in which patients suffer both from asthma and CRS, there are studies showing the effectiveness of anti-IL-5 treatment regardless of asthma, with patients benefiting from symptom relief, reduced corticosteroid use, and improved quality of life. The gene discussed is IL5; the disease is congenital rubella syndrome.